Search Results - Liu, Minzhi

Refine Results
  1. 1
    Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial

    Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial by Giorgino, Francesco, Shaunik, Alka, Liu, Minzhi, Saremi, Aramesh

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins

    Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins by Liu, Jinglong, Huan, Yi, Li, Caina, Liu, Minzhi, Shen, Zhufang

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study

    Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study by Dailey, George E., Dex, Terry A., Roberts, Michelle, Liu, Minzhi, Meneilly, Graydon S.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Engineering Saccharomyces cerevisiae with the deletion of endogenous glucosidases for the production of flavonoid glucosides

    Engineering Saccharomyces cerevisiae with the deletion of endogenous glucosidases for the production of flavonoid glucosides by Wang, Huimin, Yang, Yan, Lin, Lin, Zhou, Wenlong, Liu, Minzhi, Cheng, Kedi, Wang, Wei

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan‐L study

    iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan‐L study by Morea, Nicola, Retnakaran, Ravi, Vidal, Josep, Aroda, Vanita R., Liu, Minzhi, Saremi, Aramesh, Giorgino, Francesco

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Adenovirus Targeting to Prostate-specific Membrane Antigen through Virus-displayed Semi-random Peptide Library Screening

    Adenovirus Targeting to Prostate-specific Membrane Antigen through Virus-displayed Semi-random Peptide Library Screening by Wu, Ping, Kudrolli, Tarana A., Chowdhury, Wasim H., Liu, Minzhi M., Rodriguez, Ronald, Lupold, Shawn E.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Three-pathway combination for glutathione biosynthesis in Saccharomyces cerevisiae

    Three-pathway combination for glutathione biosynthesis in Saccharomyces cerevisiae by Tang, Liang, Wang, Weiwei, Zhou, Wenlong, Cheng, Kai, Yang, Yan, Liu, Minzhi, Cheng, Kedi, Wang, Wei

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Acrolein-stressed threshold adaptation alters the molecular and metabolic bases of an engineered Saccharomyces cerevisiae to improve glutathione production

    Acrolein-stressed threshold adaptation alters the molecular and metabolic bases of an engineered Saccharomyces cerevisiae to improve glutathione production by Zhou, Wenlong, Yang, Yan, Tang, Liang, Cheng, Kai, Li, Changkun, Wang, Huimin, Liu, Minzhi, Wang, Wei

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    More patients reach glycaemic control with a fixed‐ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time‐to‐control analysis of LixiLan‐O and LixiLan‐L

    More patients reach glycaemic control with a fixed‐ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc t... by Frias, Juan, Puig Domingo, Manuel, Meneghini, Luigi, Napoli, Raffaele, Liu, Minzhi, Soltes Rak, Erika, Aroda, Vanita R.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Efficacy of once‐daily glucagon‐like peptide‐1 receptor agonist lixisenatide as an add‐on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual‐level pooled analysis of phase III studies

    Efficacy of once‐daily glucagon‐like peptide‐1 receptor agonist lixisenatide as an add‐on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An ind... by Liu, Fuqiang, Liu, Yuan, Liu, Minzhi, Wu, Guangyu, Zhang, Minlu, Zhang, Xia, Cui, Nan, Yin, Huiqiu, Chen, Li

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

    Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin... by Rosenstock, Julio, Handelsman, Yehuda, Vidal, Josep, Ampudia Blasco, F. Javier, Giorgino, Francesco, Liu, Minzhi, Perfetti, Riccardo, Meier, Juris J.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer

    Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer by LIU, CHUNYAN, ZHANG, YONGGANG, LIU, MINZHI MAGGIE, ZHOU, HAOMING, CHOWDHURY, WASIM H., LUPOLD, SHAWN E., DEWEESE, TED L., RODRIGUEZ, RONALD

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts

    A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts by Ribas, Judit, Ni, Xiaohua, Castanares, Mark, Liu, Minzhi M., Esopi, David, Yegnasubramanian, Srinivasan, Rodriguez, Ronald, Mendell, Joshua T., Lupold, Shawn E.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    A Novel Approach for Detecting Viable and Tissue-specific Circulating Tumor Cells through an Adenovirus-based Reporter Vector

    A Novel Approach for Detecting Viable and Tissue-specific Circulating Tumor Cells through an Adenovirus-based Reporter Vector by Wu, Ping, Sokoll, Lori J., Kudrolli, Tarana A., Chowdhury, Wasim H., Ma, Rong, Liu, Minzhi M., Rodriguez, Ronald, Lupold, Shawn E.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis

    Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score... by Tabák, Ádám G., Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J., Wysham, Carol, Meier, Juris J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Effects of a ready‐to‐eat cereal formula powder on glucose metabolism, inflammation, and gut microbiota in diabetic db/db mice

    Effects of a ready‐to‐eat cereal formula powder on glucose metabolism, inflammation, and gut microbiota in diabetic db/db mice by Li, Caina, Wang, Xing, Sun, Sujuan, Liu, Shuainan, Huan, Yi, Li, Rongcui, Liu, Quan, Cao, Hui, Zhou, Tian, Lei, Lei, Liu, Minzhi, Shen, Zhufang

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Evaluation of Prostate-Specific Membrane Antigen as an Imaging Reporter

    Evaluation of Prostate-Specific Membrane Antigen as an Imaging Reporter by Castanares, Mark A., Mukherjee, Amarnath, Chowdhury, Wasim H., Liu, Minzhi, Chen, Ying, Mease, Ronnie C., Wang, Yuchuan, Rodriguez, Ronald, Lupold, Shawn E., Pomper, Martin G.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trial

    Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Explorat... by Del Prato, Stefano, Frias, Juan Pablo, Blonde, Lawrence, Aroda, Vanita R., Shehadeh, Niam, Saremi, Aramesh, Dex, Terry, Niemoeller, Elisabeth, Souhami, Elisabeth, Liu, Minzhi, Rosenstock, Julio

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes

    The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes by van Raalte, Daniël H., Bjornstad, Petter, Persson, Frederik, Powell, David R., de Cassia Castro, Rita, Wang, Ping Stella, Liu, Minzhi, Heerspink, Hiddo J.L., Cherney, David

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas

    ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas by Edwards, Lincoln A., Kim, Sungjin, Madany, Mecca, Nuno, Miriam, Thomas, Tom, Li, Aiguo, Berel, Dror, Lee, Bong-Sup, Liu, Minzhi, Black, Keith L., Fan, Xuemo, Zhang, Wei, Yu, John S.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: